Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis

Clin Immunol. 2020 Sep:218:108522. doi: 10.1016/j.clim.2020.108522. Epub 2020 Jul 16.

Abstract

Human hematopoiesis is critically dependent on the transcription factor GATA2. Patients with GATA2 deficiency typically present with myelodysplastic syndrome, reduced numbers of monocytes, NK cells and B cells, and/or opportunistic infections. Here, we present two families that harbor distinct GATA2 mutations with highly variable onset and course of disease. We discuss the use of allogeneic hematopoietic cell transplantation in these patients, especially as treatment for pulmonary alveolar proteinosis.

Keywords: Allogeneic hematopoietic stem cell transplantation; GATA2 deficiency; Pulmonary alveolar proteinosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Allografts
  • Female
  • GATA2 Deficiency / therapy*
  • GATA2 Transcription Factor / genetics
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mutation
  • Pulmonary Alveolar Proteinosis / therapy*
  • Young Adult

Substances

  • GATA2 Transcription Factor
  • GATA2 protein, human